BRAINTREE, Mass., April 6 /PRNewswire-FirstCall/ -- Haemonetics Corporation announced today that Richard Meelia has retired from its Board of Directors effective April 2, 2009. Mr. Meelia is Chairman, President and CEO of Covidien Ltd., a global healthcare products company. He is retiring from Haemonetics’ Board in order to spend more professional time on Covidien’s operations.
Brad Nutter, Chairman of Haemonetics’ Board of Directors, said, “We appreciate Rich’s leadership and guidance during his four-year tenure with Haemonetics. His breadth of experience in healthcare has been a strong complement to the Board, particularly as we’ve made key strategic decisions and transformed the Company from a niche medical device company to the global leader in blood management solutions for our customers.”
Mr. Meelia said, “During the past four years, Haemonetics made remarkable progress in transitioning into a higher growth profile company and is well positioned to deliver on its strategic and operational goals. I am proud of my association with the Company, its employees and my colleagues on the Board. There is an exciting future in store for this business.”
Haemonetics is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.
CONTACT: Julie Fallon of Haemonetics Corporation, +1-781-356-9517 or
+1-617-320-2401
Web site: http://www.haemonetics.com/
